丁化物Rh4通过SIRT1通路延缓骨肌肉的衰老
Anni Zhu1, Zhiguang Duan1, Yanru Chen2
1Shaanxi Key Laboratory of Degradable Biomedical Materials, School of Chemical Engineering, Northwest University, Xi'an, Shaanxi 710069, China; Shaanxi R&D Center of Biomaterials and Fermentation Engineering, School of Chemical Engineering, Northwest University, Xi'an, Shaanxi 710069, China; Biotech. & Biomed. Research Institute, Northwest University, Xi'an, Shaanxi 710069, China.
概括
人参中的一种化合物 - - 人参Rh4 - - 通过减少炎症和氧化损伤来对抗骨肌肉的衰老. 它激活SIRT1,改善线粒体功能并延缓肌肉衰老.
科学领域:
- 老年学和肌肉生理学
- 药理学和自然产品的研究.
背景情况:
- 骨肌肉衰老会导致老年人的身体残疾,有效治疗方法有限.
- 源自人参的金色化物Rh4具有抗炎和抗氧化特性.
研究的目的:
- 为了研究金色化物Rh4对老化骨肌肉的抗氧化作用.
- 阐明基因化物Rh4在骨肌中的抗衰老作用背后的分子机制.
主要方法:
- 利用D-银糖诱导的模型来模拟骨肌肉的衰老.
- 使用免疫光学,ELISA和电子显微镜等技术评估氧化损伤,炎症和线粒体平衡.
- 研究了SIRT1信号通路通过蛋白质免疫阻塞和免疫光的作用.
主要成果:
- 金色化物Rh4改善了肌肉纤维形态,减少了炎症.
- 它减轻了氧化损伤,恢复了线粒体平衡,并在体外减少了衰老细胞的产生.
- Rh4通过SIRT1调节PGC-1α-TFAM和HIF-1α-c-Myc通路,延缓骨肌肉的衰老.
结论:
- 人参化物Rh4有效地延迟了骨肌肉的衰老.
- 机制包括激活SIRT1,脱乙Nrf2和调节关键分子通路.
- 增强线粒体平衡,减少氧化应激和炎症.
相关概念视频
Mitochondria
13.9K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
13.9K
Skeletal Muscle Relaxants: Adverse Effects
402
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
402


